8:00 - 19:00

Working hours MON. - FRI.

Redfin’s Losses Pile Up to Keep Abreast with Demand By Investing.com

By Christiana Sciaudone Investing.com -- Redfin (NASDAQ:RDFN) plunged 14% despite the high demand for homes in pandemic times. A loss per share of 37 cents was worse than the expected 33-cent loss, according to data compiled by Investing.com. Sales beat forecasts.  "After scrambling in the second half of 2020 to hire enough agents and lenders to handle a pandemic-driven surge in demand, Redfin is just about hitting on all cylinders," said Redfin Chief Executive Officer Glenn Kelman. "From the fourth quarter of 2020 to the first quarter of 2021, our year-over-year market-share...

Подробнее

European shares end lower as oil, tech losses offset earnings boost By Reuters

By Sruthi Shankar and Ambar Warrick (Reuters) - European stocks edged lower on Thursday, with the travel sector leading declines on weak results from Britain's Trainline, while food and beverage stocks hit a 14-month high on a batch of strong earnings. The pan-European STOXX 600 index closed 0.1% lower. The travel and leisure sector was the worst performer, falling 1.7% after UK rail operator Trainline reported an annual loss. Heavyweight oil stocks were among the top drags on the STOXX 600 as oil prices slipped, while technology shares fell in tandem with their U.S. peers. (N)...

Подробнее

FTSE 100 rises as BoE holds rates, GBP weak, crude lower By Investing.com

Key Points FTSE 100 closing price of 7074.30, +0.5% Bank of England slows pace of asset purchases, interest rate on hold GBP falls as BoE signals no intention to tighten monetary policy soon John Laing shares jump after takeover interest Oil edges lower Cryptos mixed: Doge drops, Ethereum jump By Samuel Indyk Investing.com – The FTSE 100 closed at a 14-month high on Thursday after the Bank of England’s latest decision on monetary policy. The central bank decided to slow the pace of asset purchases slightly, although they made it clear this was an...

Подробнее

U.K. shares higher at close of trade; Investing.com United Kingdom 100 up 0.57% By Investing.com

Investing.com – U.K. equities were higher at the close on Thursday, as gains in the Tobacco, Mining and Healthcare Equipment & Services sectors propelled shares higher. At the close in London, the Investing.com United Kingdom 100 added 0.57% to hit a new 52-week high. The biggest gainers of the session on the Investing.com United Kingdom 100 were Fresnillo PLC (LON:FRES), which rose 6.24% or 53.20 points to trade at 906.20 at the close. British American Tobacco PLC (LON:BATS) added 3.20% or 87.0 points to end at 2803.0 and Sberbank Of Russia (LON:SBNCyq)...

Подробнее

Exclusive: UK court to reconsider $6.9 billion Brazil dam lawsuit against BHP By Reuters

By Kirstin Ridley LONDON (Reuters) - London's Court of Appeal will hear a request to revive a 5 billion pound ($6.95 billion) lawsuit against Anglo-Australian mining group BHP over a 2015 dam failure in Brazil, a court order showed. Judge Nicholas Underhill has agreed to an oral hearing that could help to overturn a previous Court of Appeal decision which denied a 200,000-strong Brazilian claimant group permission to appeal against a judgment to strike out the landmark case. "I am satisfied that, exceptionally, an oral hearing is appropriate in this case," the judge said in the...

Подробнее

FTSE 100 hits over 1-year high on strong earnings; BoE slows bond-buying By Reuters

By Devik Jain and Shivani Kumaresan (Reuters) -London's FTSE 100 hit a more than one-year high on Thursday, boosted by heavyweight consumer staple stocks and positive earnings updates from Next and Melrose Industries, while the Bank of England eased the pace of bond-buying and raised the forecast for economic growth. The blue-chip index rose 0.4%, with fashion retailer Next gaining 1.5% as it raised its profit outlook for the 2021-22 year for the second time in two months. Engineer Melrose climbed 0.8% after it said it was performing "modestly" ahead of expectations, with operating margins in...

Подробнее

Britain says it won’t seek EU access for City of London at ‘any cost’ By Reuters

LONDON (Reuters) - It would be wrong for Britain to seek access for the City of London to the European Union's markets at "any cost" if it made tailoring rules harder, the Financial Conduct Authority said on Thursday. Britain left the EU's orbit on Dec. 31 and its trade deal with the bloc does not cover financial services, leaving the City largely cut off. The EU is assessing direct financial market access for Britain under its "equivalence" rules. The bloc has said it was in no rush as it wants to know how far Britain will...

Подробнее

UniCredit’s new boss opens door to M&A after strong quarter By Reuters

By Valentina Za MILAN (Reuters) - UniCredit could consider mergers and acquisitions to drive revenue and profit growth under new CEO Andrea Orcel, who said the phase of "active retrenchment" was over for the Italian bank. Orcel's openness to M&A marks a clear shift from his predecessor, Jean Pierre Mustier, as does his pledge to revive UniCredit's lending business by ditching the risk-averse policy the French banker had opted for. In the first quarter, strong trading gains, rebounding fees and shrinking loan-loss provisions more than offset a 13% yearly drop in interest income, allowing UniCredit to...

Подробнее

Moderna, BioNTech Lead Losses on Vaccine IP Waivers By Investing.com

By Christiana Sciaudone Investing.com -- Moderna (NASDAQ:MRNA), BioNTech and Pfizer (NYSE:PFE) took the brunt of the news that the U.S. is supporting waiving intellectual property protections for Covid-19 vaccines to end the global pandemic. “The Administration believes strongly in intellectual property protections, but in service of ending this pandemic, supports the waiver of those protections for COVID-19 vaccines," said U.S. Trade Representative Katherine Tai in a statement on Wednesday. "We will actively participate in text-based negotiations at the World Trade Organization (WTO) needed to make that happen."  Moderna,...

Подробнее

UK regulator says some evidence AstraZeneca clots occur more in women than men By Reuters

LONDON (Reuters) - Britain's medicine regulator on Thursday said there was some evidence that uncommon blood clots linked to AstraZeneca (NASDAQ:AZN)'s COVID-19 vaccine occurred more in women than in men, adding that the difference in incidence was small. British officials have previously only said that the incidence of the clots was linked to age, and that a link with sex had not been established, noting that more women had been vaccinated then men. "There is now some evidence that the reported incidence rate is higher in females compared to men although this is not seen across...

Подробнее
ru_RURussian